Morimoto, Bruce H.

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

Boxer, A. L., Lang, A. E., Grossman, M., Knopman, D. S., Miller, B. L., Schneider, L. S., Doody, R. S., Lees, A., Golbe, L. I., Williams, D. R., et al. (2014) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 294

Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line

Morimoto, B. H., & Koshland, D. E. (1990) · Neuron

Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms

Cited by 149

A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment

Morimoto, B. H., Schmechel, D., Hirman, J., Blackwell, A., Keith, J., Gold, M., & on behalf of the AL-108-211 Study Investigators (2013) · Dementia and Geriatric Cognitive Disorders

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 115

Excitatory amino acid uptake and N-methyl-D-aspartate-mediated secretion in a neural cell line

Morimoto, B. H., & Koshland, D. E. (1990) · Proceedings of the National Academy of Sciences

Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and Metabolism

Cited by 49

Translatability of the S7A core battery respiratory safety pharmacology studies: Preclinical respiratory and related clinical adverse events

Paglialunga, S., Morimoto, B. H., Clark, M., & Friedrichs, G. S. (2019) · Journal of Pharmacological and Toxicological Methods

Animal testing and alternativesPharmacovigilance and Adverse Drug Reactions

Cited by 26